the inhibitory effect of lactobacillus rhamnosus gg on vancomycin resistant enterococcus faecalis colonization in mouse
Authors
abstract
similar resources
The Inhibitory Effect of Lactobacillus rhamnosus GG on Vancomycin Resistant Enterococcus faecalis Colonization in Mouse
Background&Aims: Vancomycin Resistant Enterococci (VRE) are among the most common nosocomial pathogens worldwide. The intestinal tract provides a major source for transmission of these bacteria. Probiotics are living microorganisms that moderate use of them has inhibitory effect on intestinal colonization by enteric pathogens. We examined the effect of Lactobacillus rhamnosus GG (LGG) on inhibi...
full textVancomycin-resistant Enterococcus faecalis in Serbia
criteria, and exclusion criteria available from the author). The quality of these studies is quite variable, and quality is certainly more important than quantity. Most trials of the newer agents were designed and funded by industry. In general, ciprofloxacin and levofloxacin have been studied in patient populations with more severe illnesses, including nosocomial infections, than the newer qui...
full textVancomycin-resistant Enterococcus faecium colonization in children.
Nosocomial vancomycin-resistant Enterococcus (VRE) infections have been described in only small numbers of pediatric patients. In none of these studies were multivariate analyses performed to assess which factors were independent risk factors in these patients. In the present cohort study of patients admitted to our hematology/oncology unit, surveillance cultures revealed a colonization rate of...
full text833Lactobacillus GG (LGG) Does Not Eliminate Colonization by Vancomycin Resistant Enterococcus (VRE) in Adults with Comorbidities
Background. VRE is an endemic hospital-acquired organism in the US. There are no proven methods or means of decreasing or eliminating carriage of VRE which is a risk factor for invasive disease. Two small clinical studies showed reduction or elimination of VRE colonization using the probiotic LGG but neither study cultured stool for the presence of LGG, raising questions about whether effects o...
full textVanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.
Enterococcus faecium clinical isolates A902 and BM4538, which were resistant to relatively high levels of vancomycin (128 and 64 microg/ml, respectively) and to low levels of teicoplanin (4 microg/ml), and Enterococcus faecalis clinical isolates BM4539 and BM4540, which were resistant to moderate levels of vancomycin (16 microg/ml) and susceptible to teicoplanin (0.25 microg/ml), were studied. ...
full textIn vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.
Vancomycin resistance exhibited by Enterococcus faecalis isolates V583, V586, and V587 is described. The vancomycin MICs ranged from 32 to 64 micrograms/ml. Although resistant to vancomycin, the isolates were susceptible to teicoplanin (MIC, less than or equal to 0.5 micrograms/ml). Such a glycopeptide susceptibility profile has not been previously described for E. faecalis. Time kill studies s...
full textMy Resources
Save resource for easier access later
Journal title:
research in pharmaceutical sciencesجلد ۷، شماره ۵، صفحات ۰-۰
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023